Please try another search
ChemoMetec A/S reported earnings results for the full year ended June 30, 2023. For the full year, the company reported sales was DKK 442.27 million compared to DKK 427.16 million a year ago. Net income was DKK 178.67 million compared to DKK 159.47 million a year ago. Basic earnings per share from continuing operations was DKK 10.27 compared to DKK 9.16 a year ago. Diluted earnings per share from continuing operations was DKK 10.27 compared to DKK 9.16 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 99.9 | 99.9 | 100.87 | 100.87 |
Gross Profit | 89.82 | 89.82 | 91.33 | 91.33 |
Operating Income | 42.32 | 42.32 | 47.9 | 47.9 |
Net Income | 35.28 | 35.28 | 36.62 | 36.62 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 593.51 | 593.51 | 657.98 | 657.98 |
Total Liabilities | 94.78 | 94.78 | 124.93 | 124.93 |
Total Equity | 498.73 | 498.73 | 533.04 | 533.04 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 20.41 | 20.41 | 52.95 | 52.95 |
Cash From Investing Activities | -9.23 | -9.23 | -8.4 | -8.4 |
Cash From Financing Activities | -53 | -53 | -0.724 | -0.724 |
Net Change in Cash | -42.21 | -42.21 | 46.07 | 46.07 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review